Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Brugger

Showing results (21-30 of 120) with videos related to

Pageof 12
Sort By:
British Journal of Haematology|October 1, 1991
Combination of cytokines: current status and future prospectsL Kanz, W Brugger, K Bross, et al.
Stem Cells (Dayton, Ohio)|April 1, 2000
Clinical applications of CD34(+) peripheral blood progenitor cells (PBPC)W Vogel, S Scheding, L Kanz, et al.
Experimental Hematology|November 8, 2001
Dendritic cells in cancer vaccinesP Brossart, S Wirths, W Brugger, et al.
Acta Haematologica|January 1, 1991
Clinical role of colony stimulating factorsW Brugger, F M Rosenthal, L Kanz, et al.
Bailliere'S Best Practice & Research. Clinical Haematology|September 23, 2000
Clinical use for expanded peripheral blood stem cellsT A Bock, S Scheding, W Brugger, et al.
Blood|August 24, 1999
Expression of laminin beta2 chain in normal human bone marrowW Vogel, L Kanz, W Brugger, et al.
Seminars in Oncology|February 1, 1995
Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancerW Brugger, H Frommhold, K Pressler, et al.
Nuklearmedizin. Nuclear Medicine|April 1, 1995
[Immunoscintigraphy of bone marrow in plasmacytoma]J Bathmann, W Brugger, C Ullrich, et al.
Deutsche Medizinische Wochenschrift (1946)|March 6, 2014
[Potentially curative surgical therapy in oligometastatic non-small cell lung cancer]T Plönes, S Dango, W Brugger, et al.
Stem Cells (Dayton, Ohio)|January 1, 1997
Purging of peripheral blood progenitor cell autografts and treatment of minimal residual diseaseW Brugger, S Scheding, T Bock, et al.
Pageof 12

Showing results (21-30 of 120) with videos related to

Sort By:
Pageof 12
British Journal of Haematology|October 1, 1991
Combination of cytokines: current status and future prospectsL Kanz, W Brugger, K Bross, et al.
Stem Cells (Dayton, Ohio)|April 1, 2000
Clinical applications of CD34(+) peripheral blood progenitor cells (PBPC)W Vogel, S Scheding, L Kanz, et al.
Experimental Hematology|November 8, 2001
Dendritic cells in cancer vaccinesP Brossart, S Wirths, W Brugger, et al.
Acta Haematologica|January 1, 1991
Clinical role of colony stimulating factorsW Brugger, F M Rosenthal, L Kanz, et al.
Bailliere'S Best Practice & Research. Clinical Haematology|September 23, 2000
Clinical use for expanded peripheral blood stem cellsT A Bock, S Scheding, W Brugger, et al.
Blood|August 24, 1999
Expression of laminin beta2 chain in normal human bone marrowW Vogel, L Kanz, W Brugger, et al.
Seminars in Oncology|February 1, 1995
Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancerW Brugger, H Frommhold, K Pressler, et al.
Nuklearmedizin. Nuclear Medicine|April 1, 1995
[Immunoscintigraphy of bone marrow in plasmacytoma]J Bathmann, W Brugger, C Ullrich, et al.
Deutsche Medizinische Wochenschrift (1946)|March 6, 2014
[Potentially curative surgical therapy in oligometastatic non-small cell lung cancer]T Plönes, S Dango, W Brugger, et al.
Stem Cells (Dayton, Ohio)|January 1, 1997
Purging of peripheral blood progenitor cell autografts and treatment of minimal residual diseaseW Brugger, S Scheding, T Bock, et al.
Pageof 12